4.7 Article

Multidimensional optimization of promising antitumor xanthone derivatives

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 21, 期 11, 页码 2941-2959

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2013.03.079

关键词

Xanthones; Xanthen-9-ones; Antitumor; Benzopyran; Chromans; Chromene; Lipophilicity; Solubility

资金

  1. FCT-Fundacao para a Ciencia e Tecnologia [CEQUIMED-PESt.OE/SAU/UI4040/2011]
  2. FEDER funds through the COMPETE program [FCOMP-01-0124-FEDER-011057]
  3. FCT [PTDC/SAU-FCT/100930/2008, SFRH/BD/41165/2007, SRH/BPD/68787/2010]
  4. Santander Totta
  5. FAPESP (Brazil)
  6. CAPES (Brazil)
  7. Fundação para a Ciência e a Tecnologia [SFRH/BD/41165/2007] Funding Source: FCT

向作者/读者索取更多资源

A promising antitumor xanthone derivative was optimized following a multidimensional approach that involved the synthesis of 17 analogues, the study of their lipophilicity and solubility, and the evaluation of their growth inhibitory activity on four human tumor cell lines. A new synthetic route for the hit xanthone derivative was also developed and applied for the synthesis of its analogues. Among the used cell lines, the HL-60 showed to be in general more sensitive to the compounds tested, with the most potent compound having a GI(50) of 5.1 mu M, lower than the hit compound. Lipophilicity was evaluated by the partition coefficient (K-p) of a solute between buffer and two membrane models, namely liposomes and micelles. The compounds showed a log K-p between 3 and 5 and the two membrane models showed a good correlation (r(2) = 0.916) between each other. Studies concerning relationship between solubility and structure were developed for the hit compound and 5 of its analogues. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据